Intersect ENT Reports Second Quarter 2014 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: Intersect ENT (XENT) Posts Q2 Loss of $2.36/Share
September 3, 2014 4:40 PM EDT(Updated - September 3, 2014 4:41 PM EDT)
Intersect ENT (Nasdaq: XENT) reported Q2 EPS of ($2.36), versus analyst estimate of ($2.59). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $8.46 million.
For earnings history and earnings-related data on (XENT) click here.
... More